-
Uncategorized2 months ago
Shedding light on the undiscovered pathways of yeast metabolism
Post Content
-
Uncategorized2 months ago
Historic FDA approval brings first gene therapy for genetic deafness
Nature Biotechnology, Published online: 28 April 2026; doi:10.1038/s41587-026-03145-w The first-of-its-kind genetic medicine treats a rare and profound otoferlin-related hearing loss, and will be made available by...
-
Uncategorized2 months ago
Retron-Powered Approach Enables Genome Editing Across Diverse Bacterial Species
For decades, the ability to precisely rewrite bacterial genomes has been largely confined to a single workhorse organism: Escherichia coli. That limitation has slowed efforts to...
-
Uncategorized2 months agoNew U.S. recommendation on hepatitis B vaccine will have dire consequences, studies project
A new U.S. policy that recommends offering hepatitis B vaccine at birth only to babies perceived to be at risk of neonatal infection will lead to...
-
Uncategorized2 months agoSTAT+: Erasca touts strong, though preliminary, results in trial of pancreatic and lung cancer therapy
The drugmaker Erasca said Monday that its RAS-targeting pill shrank tumors in 40% of patients with advanced pancreatic cancer and 62% of patients with advanced non-small...
-
Uncategorized2 months ago
Erasca reports RAS cancer drug data after legal threat from Revolution
Erasca reports RAS cancer drug data after legal threat from Revolution
-
Uncategorized2 months ago
Sun Pharma Aims for Top 3 in Women’s Health with $11.75B Organon Purchase
Sun Pharmaceutical Industries has agreed to acquire Organon, the women’s health drug developer spun out of Merck & Co., for $11.75 billion in a deal intended...
-
Uncategorized2 months agoDems say RFK Jr. has a pattern of failing to answer their questions
WASHINGTON — Last week, Sen. Ben Ray Luján (D-N.M.) asked health secretary Robert F. Kennedy Jr. whether he would release — by Friday — the contract...
-
Uncategorized2 months ago
Revolution Medicines threatens to sue Erasca over patent, efficacy claims
Revolution Medicines threatens to sue Erasca over patent, efficacy claims
-
Uncategorized2 months agoTrump administration warns against using federal dollars on fentanyl test strips
The Trump administration is doubling down on its opposition to harm reduction services for people who use illicit drugs. In an open letter on April 24,...
FDA’s new voucher program hints at broader policy agenda, making many ‘uncomfortable’
STAT+: CMS recalculates Medicare Advantage star ratings again, adding more volatility to program
